Tuberculosis diagnostic accuracy of stool Xpert MTB/RIF and urine AlereLAM in vulnerable children
- 1 January 2022
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 59 (1), 2101116
- https://doi.org/10.1183/13993003.01116-2021
Abstract
Background Non-sputum-based diagnostic approaches are crucial in children at high risk of disseminated tuberculosis (TB) who cannot expectorate sputum. We evaluated the diagnostic accuracy of stool Xpert MTB/RIF and urine AlereLAM tests in this group of children. Methods Hospitalised children with presumptive TB and either age <2 years, HIV-positive or with severe malnutrition were enrolled in a diagnostic cohort. At enrolment, we attempted to collect two urine, two stool and two respiratory samples. Urine and stool were tested with AlereLAM and Xpert MTB/RIF, respectively. Respiratory samples were tested with Xpert MTB/RIF and mycobacterial culture. Both a microbiological and a composite clinical reference standard were used. Results The study analysed 219 children; median age 16.4 months, 72 (32.9%) HIV-positive and 184 (84.4%) severely malnourished. 12 (5.5%) and 58 (28.5%) children had confirmed and unconfirmed TB, respectively. Stool and urine were collected in 21,9 (100%) and 216 (98.6%) children, respectively. Against the microbiological reference standard, the sensitivity and specificity of stool Xpert MTB/RIF was 50.0% (6/12, 95% CI 21.1-78.9%) and 99.1% (198/200, 95% 96.4-99.9%), while that of urine AlereLAM was 50.0% (6/12, 95% 21.1-78.9%) and 74.6% (147/197, 95% 67.9-80.5%), respectively. Against the composite reference standard, sensitivity was reduced to 11.4% (8/70) for stool and 26.2% (17/68) for urine, with no major difference by age group (= 2 years) or HIV status. Conclusions The Xpert MTB/RIF assay has excellent specificity on stool, but sensitivity is suboptimal. Urine AIereLAM is compromised by poor sensitivity and specificity in children.Funding Information
- Médecins Sans Frontières
This publication has 35 references indexed in Scilit:
- Urine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective studyThe Lancet. Global Health, 2014
- Reasons for false-positive lipoarabinomannan ELISA results in a Tanzanian populationScandinavian Journal of Infectious Diseases, 2013
- Xpert MTB/RIF Testing of Stool Samples for the Diagnosis of Pulmonary Tuberculosis in ChildrenClinical Infectious Diseases, 2013
- Foul Smelling Urine in a 7-year-old Boy Caused by Aerococcus urinaeThe Pediatric Infectious Disease Journal, 2012
- Rapid Diagnosis of Pediatric Intrathoracic Tuberculosis From Stool Samples Using the Xpert MTB/RIF AssayThe Pediatric Infectious Disease Journal, 2012
- Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art reviewBMC Infectious Diseases, 2012
- Diagnostic Accuracy of a Urine Lipoarabinomannan Enzyme-Linked Immunosorbent Assay for Screening Ambulatory HIV-Infected Persons for TuberculosisJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Novel lipoarabinomannan-like lipoglycan (CdiLAM) contributes to the adherence of Corynebacterium diphtheriae to epithelial cellsArchiv für Mikrobiologie, 2008
- TUBERCULOSIS IN CHILDRENPrimary Care: Clinics in Office Practice, 1996